Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Pharmaceutics International, Inc.
FDA Inspection
•Pharmaceutics International, Inc.•October 27, 2017

Pharmaceutics International, Inc. – FDA Inspection, Oct 27, 2017

Record Details

This FDA Inspection record concerns Pharmaceutics International, Inc., with an inspection on October 27, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Pharmaceutics International, Inc.
Inspection Date
October 27, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Jonathan W. Chapman (Company Rep)
  • Marcus A. Ray (FDA Associated Person)
  • Thomas E. Friel (FDA Associated Person)
View Company Profile

ID · 210de1ab-41c0-407d-a223-367de4d1e793

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1030024
FDA center
Human Drugs
Project area
Generic Drug Evaluation
Outcome
Form 483 issued

FDA Citations

8
  1. 21 CFR 211.110(a)Control procedures fail to include the following
  2. 21 CFR 211.113(b)Procedures for sterile drug products
  3. 21 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
  4. 21 CFR 211.192Investigations of discrepancies, failures
  5. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  6. 21 CFR 211.63Equipment Design, Size and Location
  7. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  8. 21 CFR 211.68(b)Computer control of master formula records

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Pharmaceutics International, Inc.

10
DateClassificationOfficeProject area
March 6, 2026Not classifiedBaltimore District OfficeDrug Quality Assurance
June 12, 2024NAICenter for Devices and Radiological HealthCompliance: Devices
November 14, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 29, 2021VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 10, 2020NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 10 other inspections on the company page
Other documents for Pharmaceutics International, Inc.
  • FDA Inspection 1307080 - 2026-03-06
  • FDA Inspection 1244595 - 2024-06-12
  • FDA Inspection 1194409 - 2022-11-14
  • FDA Inspection 1155191 - 2021-09-29
  • FDA Inspection 1124545 - 2020-07-10

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmaceutics International, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.